| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 328 |
| 1 | ASPIRIN 325 MG | 323 |
| 2 | ASPIRIN 81 MG | 323 |
| 3 | PROPOFOL | 205 |
| 4 | CLOPIDOGREL | 179 |
| 5 | FLUOROURACIL | 150 |
| 6 | FLUOROURACIL CREAM, 0.5% | 150 |
| 7 | CLOPIDOGREL BISULFATE | 145 |
| 8 | FUROSEMIDE | 140 |
| 9 | OXALIPLATIN | 116 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PROPOFOL INJECTABLE EMULSION | 4 | 0.0360 |
| 1 | COCAINE HYDROCHLORIDE NASAL | 2 | 0.0308 |
| 2 | TECHNESCAN TC 99M MERTIATIDE | 2 | 0.0194 |
| 3 | CARBON DIOXIDE | 2 | 0.0174 |
| 4 | AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | 1 | 0.0156 |
| 5 | VECURONIUM BROMIDE | 20 | 0.0131 |
| 6 | CANGRELOR | 5 | 0.0124 |
| 7 | ACETYLCHOLINE CHLORIDE | 1 | 0.0102 |
| 8 | ANGIOTENSIN II | 3 | 0.0100 |
| 9 | FELBAMATE | 16 | 0.0090 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 498 |
| 1 | Platelet Aggregation Inhibitor [EPC] | 331 |
| 2 | Corticosteroid [EPC] | 270 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 252 |
| 4 | Benzodiazepine [EPC] | 241 |
| 5 | Atypical Antipsychotic [EPC] | 238 |
| 6 | General Anesthetic [EPC] | 227 |
| 7 | Platinum-based Drug [EPC] | 201 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 175 |
| 9 | P2Y12 Platelet Inhibitor [EPC] | 174 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vasoconstrictor [EPC] | 3 | 0.0100 |
| 1 | General Anesthetic [EPC] | 227 | 0.0052 |
| 2 | Adenosine Receptor Agonist [EPC] | 37 | 0.0050 |
| 3 | Contrast Agent for Ultrasound Imaging [EPC] | 27 | 0.0046 |
| 4 | Benzodiazepine Antagonist [EPC] | 4 | 0.0045 |
| 5 | Endoglycosidase [EPC] | 8 | 0.0043 |
| 6 | alpha-1 Adrenergic Agonist [EPC] | 15 | 0.0034 |
| 7 | Dopamine-2 Receptor Antagonist [EPC] | 16 | 0.0021 |
| 8 | Radiographic Contrast Agent [EPC] | 50 | 0.0019 |
| 9 | Methylating Agent [EPC] | 2 | 0.0019 |